phase leukemia cells collected more than 6 months before the onset of L-BT in three of these patients. Of the other three patients studied in chronic phase from 1 to 6 months before L-
of L-BT did not reveal clonal involvement of chromosome 14 in any of the cases studied. Material from 10 patients with myeloid BT and peripheral blood from 10 normal volunteers was also analyzed. Informed consent was obtained in all Introduction instances. Lymphoid blastic transformation (L-BT) accounts for approximately one third of the blast crises occurring in progressive Mononuclear cells/DNA preparation/Southern blot chronic myeloid leukemia (CML). There is a reasonable likelianalyses hood of achieving a second chronic phase following L-BT with appropriate combination chemotherapy, 1 which may Peripheral blood or bone marrow mononuclear cells were allow more successful utilization of allogeneic transplantation obtained by centrifugation on Lymphoprep (Nycomed, Oslo, when compared to using the same treatment during blast Norway), pelleted and frozen at −70°C prior to use. DNA was crisis.
2,3 L-BT is phenotypically similar to acute lymphoblastic then extracted and purified and Southern blot analyses were leukemia (ALL). 4 Furthermore, analysis of the immunoglobulin performed using a J H probe following digestion with HindIII heavy chain (IgH) gene loci by Southern blotting 5 suggests and BglII as previously described. 12 that, as in ALL, rearrangement of one or more of the genes may serve as molecular markers of the transformed clone or clones. CD10 CD13 CD14 CD19 CD33  CD34  TdT  HLA-DR   1  F  53  8.0  50  49  21  21  92  1  3  84  11  70  73  90  2  M  18  3.3  60  60  ND  ND  80  70  ND  70  50  55  ND  ND  3  M  50  62.7  50  20  3  4  97  3  2  96  15  2  96  98  4  F  32  96.6  50  5  20  7  96  20  2  93  23  75  86  95  5  M  28  55.5  70  133  3  2  75  15  3  25  ND  ND  95  ND  6  M  32  9.0  22  39  ND  ND  23  20  1  3  6  53  18  84  7  M  45  65.6  54  NA  ND  ND  ND  ND  ND  ND  ND  ND  ND  ND  8  M  24  13.5  30  77  8  5  76  7  4  78  3  ND  93  83  9  M  34  45.6  20  67  12  5  54  3  2  49  1  ND  86  80  10  M  37  144.0  25  20  ND  ND  ND  ND  ND  ND  ND  ND  ND  ND  11  F  43  182.7  30  1  9  3  80  2  ND  84  9  33  87  92  12  M  17  42.6  90  10  3  2  82  3  4  83  5  69  56  81  13  M  72  62.7  40  34  9  47  86  75  ND  62  23  2  60  ND   a Number of positive cells expressed as a percentage. b n × 10 9 /l. WC, white cell count; BC, peripheral blood blast percentage; CD, cluster of differentiation; CP duration, duration of chronic phase prior to blastic transformation; NA, not available; ND, not determined. each dATP, dCTP, dGTP and dTTP, 0.5 m of each primer, (V H 1 to V H 6/CJH) or 8% (NV2/NJ2 and FR3/NJ2) polyacrylamide gels and visualised after overnight exposure to radio-0.2 U Taq polymerase and 0.5-1.0 g of genomic DNA template. Amplification was carried out on a programmable heatgraphic film at −70°C. All PCR reactions and polyacrylamide electrophoreses were performed at least twice to ensure reproing block (MJ Research, Watertown, MA, USA) by 36 cycles of 96°C for 30 s, 60°C for 50 s and 72°C for 1 min followed ducibility of the results. by a 10 min extension at 72°C. The V H family-specific primers (V H 1 to V H 6) each in combination with CJH (seven separate PCR reactions) were used at a concentration of 0.3 m and an Sequencing annealing temperature of 62°C but conditions were otherwise identical. PBMC DNA from a normal individual was included Following amplification with the NV2/NJ2 primers the band(s) on the polyacrylamide gels corresponding to clonal CDR3 in each experiment to show that adequate amplification and radioactive labelling had occurred.
rearrangements were excised (both bands in patient No. 12 L-BT, otherwise the predominant band if more than one In each case a 5 l aliquot of reaction product was electrophoresed on a 2% agarose gel to confirm adequate amplirearrangement was present). The DNA was eluted and reamplified using the same set of primers. The products were fication. A 1 l aliquot of each was then reamplified with the same primers and under the same conditions incorporating purified using polyethylene glycol precipitation, visualised on 2% agarose gels to confirm purity and then sequenced on an 32 P dCTP. The products were then electrophoresed on 6% CDR3-specific PCR with the V H family-specific primers giving the same overall detection rate of 85%. More than one PCR detectable A primer (J498) complementary to the sequenced D-N-J region of the CDR3 rearrangement detected during the rearrangement was present in 64% and Ͼ2 in 27% of the informative cases. V H 3 and V H 1 were the most commonly chronic phase of patient No. 12 was designed. PCR was then carried out on the patient's sequential CP and L-BT material detected variable genes. In general, the variable gene utilization, apart from an apparent under-utilization of V H 4, using primer J498 in combination with both the V H 1 gene family-specific primer and with a V H gene family consensus reflected the proportions of each V H family within the germline repertoire. The predominant clone(s) at the time of L-BT primer FR1c. 7 The products were then visualized on polyacrylamide gels as previously described.
were sequenced in six patients (Table 3 ). In all instances comparison with previously published germline diversity and joining gene sequences revealed no evidence of somatic mutation.
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Results
Lymphoid blastic transformation Chronic phase
No clonal rearrangements were detected in any of the myeloid BT patients or normal individuals analyzed. ImmunophenoChronic phase material was available for analysis at various intervals prior to the development of L-BT from six patients: typing and Southern blotting results for patients in L-BT are shown in Tables 1 and 2 . Four of these patients (Nos 2, 4, 6 and 9) had no clonal rearrangement was seen in all but one of the 10 cases analyzed by Southern blotting (Table 2) , a germline configuration rearrangements detected. Clonal rearrangements were detected by PCR but not by Southern blot analysis in patient being found in one of the cases with bi-lineage transformation. prior to L-BT two rearrangements were visible, one of which was identical in size to V H 3/D21-9/J H 4b. Sequencing showed and joining genes utilized were readily identifiable from previously described germline sequences 8, [13] [14] [15] [16] [17] [18] and on comparithat the other larger rearrangement was V H 5/D21-9/J H 4b (Figure 2 ). In addition to identical D-J H utilization and the N son showed no evidence of somatic mutation, as has been described in ALL. 8 This likely explains the low PCR false negaregion between the D H and J H segments there was also identity of the three most 3′ V H -D join N-nucleotides (Table 3 ) tivity rate, in contrast to the situation in myeloma and follicular NHL. 7 between the CP and L-BT rearrangements. The most likely explanation for the disappearance of the V H 5/D21-9/J H 4b We have found two or more rearrangements in over half of the informative cases analyzed which is consistent with the rearrangement is clonal evolution secondary to a V H to V H -D-J H substitution occurring more than 3 months prior to L-BT findings in ALL. 20, 21 Steenbergen et al 22 reported a case of lymphoid blastic transformation of CML in which both related utilizing the conserved 3′ V H heptamers TACTGTG 24 present in both rearrangements (not shown). A previously germline and unrelated IgH gene rearrangements were detectable in the same patient. They attributed this to transformation occurring V H 3 gene would have replaced the more J H -proximal V H 5 gene and in the same rearrangement process a 5′ 20 bp in a B cell precursor prior to and competent for IgH gene rearrangement. An alternative hypothesis, and one which deletion of the CP V H -D join could have occurred.
The degree of identity between the CP and L-BT rearrangewould also explain the presence of unrelated lymphoid blastic clones in sequential transformations 23 can be proposed. That ments argues against the alternative explanation, namely two independent V H to D-J H rearrangements occurring in a transis, that in a subgroup of CML patients, primitive BCR-ABLpositive cells committed to B lymphoid differentiation acquire formed D21-9/J H 4b rearrangement B cell precursor. In patient No. 12 both the Southern blot and the V H 3 family genetic abnormalities producing significant genomic instability within a pool of self-renewing B lymphoid progenitors.
primer PCR amplification (Figure 2 ) revealed two bands at the time of L-BT with no evidence of a germline band on the Further mutations(s) representing the final transformation No.
The 20 base pairs deleted in the V H 3 to V H 5/D21-9/J H 4b substitution are underscored. b Germline diversity gene from which rearranged segment is derived is shown in bold lettering. Southern blot (not shown). Taken together this is consistent ative therapy. 27, 28 The present study is however the first to provide evidence that in some CML patients a state of 'clonal with bi-allelic IgH gene rearrangement within a single transformed clone at the time of L-BT. Using the V H 1 family primer instability' may exist during an otherwise typical CP with spontaneous clonal succession preceding the emergence of a two rearrangements were also detectable 5 months prior to the onset of L-BT. Sequencing revealed the predominant CP dominant blastic clone. Indeed, this is not inconsistent with the hypothesis we have proposed as a possible explanation rearrangement to be V H 1/DXP4/J H 6c. Despite the obvious amplification of residual V H 1 utilizing lymphopoiesis both 1 for the presence of unrelated IgH gene rearrangements at the time of diagnosis of L-BT. Kitchingham 29 proposed that the month prior to and at the time of L-BT no band of a size corresponding to the V H 1/DXP4/J H 6c clone was detectable. Fur-VDJ recombinase system may be especially active in the target cells at the time of disease onset in a high percentage of ALL thermore, the two rearrangements at the time of L-BT, V H 3/D21-9/J H 6c and V H 3/DLR1/J H 4b were completely unrepatients leading to genomic instability. It is possible that a similar mechanism operates in patients with CML heralding lated to the preceding chronic phase rearrangement (Table 3) . In view of these observations, the proposed mechanism the onset of blast crisis.
In conclusion, we have demonstrated the reliability and underlying the clonal evolution in patient No. 3 could not have been responsible in this instance and clonal succession specificity of the IgH PCR assay in confirming the lineage of blastic transformation of CML. In some patients clonal IgH is a more appropriate description. This was confirmed by the CDR3-specific PCR (Figure 3 ) which was positive 5 months rearrangements detectable in the peripheral blood during apparently stable chronic phase may be a sensitive marker prior to the L-BT but at no other time point analyzed.
The ability of the V H 3 clone in patient No. 12 to produce of clonal instability and impending disease progression. It is uncertain if the same results would be obtained using bone a clinical picture consistent with L-BT and the inability of the V H 1 clone to do so, imply the presence of important biological marrow. We are currently investigating whether such 'abortive' rearrangements are detected only in the peripheral blood difference(s) between the two. Whereas both were capable of clonal expansion the latter failed to progress and generate a of patients destined to develop lymphoid rather than myeloid BT and whether their timing is such that this technique could clinical L-BT. Indeed, after only a transient appearance, the V H 1 clone fell below the level of detection of the CDR3-spebe used to monitor chronic phase patients. cific PCR assay, possibly undergoing 'clonal deletion'. This suggests the probable absence within the V H 1 clone of a genetic abnormality essential for indefinite clonal survival. Such an abnormality must have been present in the V H 3 clone and Acknowledgements enabled this cell population to expand and establish a true blastic transformation.
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